Countering the classical renin-angiotensin system.

Countering the classical renin-angiotensin system.
复制标题

对抗经典的肾素-血管紧张素系统。

DOI:
10.1042/cs20211043
复制
发表时间:
2021
期刊:
Clinical science (London, England : 1979)
影响因子:
--
通讯作者:
Speth,RobertC
Speth,RobertC
中科院分区:
--
文献类型:
--
作者:
Noto,NataliaM;Restrepo,YazminM;Speth,RobertC

文献摘要

参考文献

相似文献

已经确定,Ang-(1-7)通过与各种受体的相互作用,抵消外周中Ang II的作用,同时刺激加压素释放并模拟脑中Ang II的活性。Ang-(1-7)的快速代谢失活已被证明是对肽的治疗性施用的限制。为了避免这个问题,Alves等人(Clinical Science(2021)135(18),https://doi.org/10.1042/CS20210599)开发了一种新的转基因大鼠模型,其过表达产生Ang-(1-7)的融合蛋白。在这篇评论中,我们讨论了这种模式的潜在问题,同时也强调了这一重大技术成就可能带来的进步。
It is well-established that Ang-(1-7) counteracts the effects of Ang II in the periphery, while stimulating vasopressin release and mimicking the activity of Ang II in the brain, through interactions with various receptors. The rapid metabolic inactivation of Ang-(1-7) has proven to be a limitation to therapeutic administration of the peptide. To circumvent this problem, Alves et al. (Clinical Science(2021)135(18), https://doi.org/10.1042/CS20210599) developed a new transgenic rat model that overexpresses an Ang-(1-7)-producing fusion protein. In this commentary, we discuss potential concerns with this model while also highlighting advances that can ensue from this significant technical feat.
DOI: 10.1042/cs20200570
发表时间: 2020-10
期刊: Clinical science
影响因子: 6
作者:
Qiuhong Li;M. Grant;E. Richards;M. Raizada
通讯作者: Qiuhong Li;M. Grant;E. Richards;M. Raizada
DOI: 10.1093/cvr/cvr242
发表时间: 2011-12-01
影响因子: 10.8
作者:
Sriramula, Srinivas;Cardinale, Jeffrey P.;Francis, Joseph
通讯作者: Francis, Joseph
DOI: --
发表时间: 2013-05
期刊: Missouri medicine
影响因子: --
作者:
E. Bryda
通讯作者: E. Bryda
新型血管紧张素肽可调节血压、内皮功能和尿钠排泄。
DOI: 10.1681/asn.v991716
发表时间: 1998
期刊: Journal of the American Society of Nephrology : JASN
影响因子: --
作者:
Ferrario,CM;Chappell,MC;Dean,RH;Iyer,SN
通讯作者: Iyer,SN
DOI: 10.1161/01.hyp.0000113047.47711.fa
发表时间: 2004-02-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
DiBona, GF
通讯作者: DiBona, GF